Synergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria

Background The alarming increase in drug resistance and decreased production of new antibiotics necessitate the evaluation of combinations of existing antibiotics. Fosfomycin shows no cross-resistance to other antibiotic classes. Thus, its combination with other antibiotics may potentially show syne...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of clinical pharmacology 2010-04, Vol.66 (4), p.359-368
Hauptverfasser:	Kastoris, Antonia C., Rafailidis, Petros I., Vouloumanou, Evridiki K., Gkegkes, Ioannis D., Falagas, Matthew E.
Format:	Artikel
Sprache:	eng
Schlagworte:	Acinetobacter baumannii Acinetobacter baumannii - drug effects Amikacin - pharmacology Amikacin - therapeutic use Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Antibiotics Bacteria Bacteria - drug effects Biological and medical sciences Biomedical and Life Sciences Biomedicine Ceftazidime - pharmacology Ceftazidime - therapeutic use Cephalosporins - pharmacology Ciprofloxacin - pharmacology Ciprofloxacin - therapeutic use Drug therapy Enterobacteriaceae Enterobacteriaceae - drug effects Enterococcus Fosfomycin - pharmacology Fosfomycin - therapeutic use Gentamicins - pharmacology Gentamicins - therapeutic use Gram-Negative Bacteria - drug effects Gram-Negative Bacteria - isolation & purification Medical sciences Methicillin Resistance - drug effects Pharmacodynamics Pharmacology. Drug treatments Pharmacology/Toxicology Pseudomonas aeruginosa Staphylococcus aureus Streptococcus pneumoniae
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!